Gürtürk K, Ekin I H, Aksakal A, Solmaz H
Yüzüncü Yil Universitesi and Veteriner Fakültesi, Mikrobiyoloji Anabilim Dali, Türkiye.
J Vet Med B Infect Dis Vet Public Health. 2002 Apr;49(3):146-51. doi: 10.1046/j.1439-0450.2002.00524.x.
In this study, a dot-enzyme-linked immunosorbent assay (Dot-ELISA) was evaluated in comparison with a complement fixation test (CFT) for the detection of Campylobacter antibodies in sheep sera. Acid glycine extracts (AGE) of both Campylobacter fetus ssp. fetus and Campylobacter jejuni strains that had been isolated from the gall-bladder of slaughtered sheep was used as antigen in both tests. A total of 153 sheep sera from aborted (74) and slaughtered (79) sheep were examined by both Dot-ELISA and CFT. Twenty-two sera showed anti-complementary activity were not suitable for CFT. Of the 22 sera showing anti-complementary activity, two sera were found to be positive in Dot-ELISA. Eighty-eight (67.2%) of the remaining 131 sera were negative by both Dot-ELISA and CFT using AGE of both Campylobacter strains whereas 43 sera (32.8%) gave different reaction patterns in Dot-ELISA and CFT with the extracts of both Campylobacter strains. Twelve sera were positive by both tests using AGE of C. fetus ssp. fetus but CFT failed to detect antibodies in nine of these sera when AGE of C. jejuni was used. Twelve sera were positive by both tests only when AGE of C. fetus ssp. fetus was used. Eleven sera were positive only by CFT. Seven of these reacted only with the AGE of C. fetus ssp. fetus and four sera were positive by using AGE of both Campylobacter strains. The remaining eight sera were found to be positive only by dot-immunobinding assay either with the AGE of both Campylobacter strains or with the AGE of one of the Campylobacter strains. It is concluded that Dot-ELISA using AGE from C. fetus ssp. fetus could be employed for the detection of Campylobacter antibodies in sheep sera and the additional use of AGE from C. jejuni as antigen appeared not to be profitable for this purpose.
在本研究中,对斑点酶联免疫吸附测定法(Dot-ELISA)与补体结合试验(CFT)进行了评估,以检测绵羊血清中的弯曲杆菌抗体。胎儿弯曲杆菌胎儿亚种和从屠宰绵羊胆囊中分离出的空肠弯曲杆菌菌株的酸性甘氨酸提取物(AGE)在两种试验中均用作抗原。通过Dot-ELISA和CFT对总共153份来自流产(74份)和屠宰(79份)绵羊的血清进行了检测。22份显示抗补体活性的血清不适合用于CFT。在这22份显示抗补体活性的血清中,有两份血清在Dot-ELISA中呈阳性。使用两种弯曲杆菌菌株的AGE,其余131份血清中的88份(67.2%)通过Dot-ELISA和CFT均为阴性,而43份血清(32.8%)在Dot-ELISA和CFT中对两种弯曲杆菌菌株提取物的反应模式不同。使用胎儿弯曲杆菌胎儿亚种的AGE时,12份血清在两种试验中均呈阳性,但使用空肠弯曲杆菌的AGE时,CFT未能检测出其中9份血清中的抗体。仅在使用胎儿弯曲杆菌胎儿亚种的AGE时,12份血清在两种试验中均呈阳性。11份血清仅通过CFT呈阳性。其中7份仅与胎儿弯曲杆菌胎儿亚种的AGE反应,4份血清使用两种弯曲杆菌菌株的AGE时呈阳性。其余8份血清仅通过斑点免疫结合试验呈阳性,使用的是两种弯曲杆菌菌株的AGE或其中一种弯曲杆菌菌株的AGE。结论是,使用胎儿弯曲杆菌胎儿亚种的AGE的Dot-ELISA可用于检测绵羊血清中的弯曲杆菌抗体,额外使用空肠弯曲杆菌的AGE作为抗原似乎对该目的无益处。